glp 1 agonist drugs side effects GLP-1 medication for diabetes and weight loss Table 2 from Optimizing Outcomes

Unlike earlier single- or dual-target peptides, this multi-receptor agonist regulates hunger, maintains glucose balance, and burns energy all within a single molecular structure

KosiborodMNAbildstrmSZBorlaugBAButlerJChristensenLDaviesMet alDesign and baseline characteristics of STEP-HFpEF program evaluating semaglutide in patients with obesity HFpEF phenotype

Human epicardial fat expresses glucagon-like peptide 1 and 2 receptors genes

doi: 10.1101/gad.1742509

A newer finding from Phase 3 data is dysesthesia (skin tingling or sensitivity) affecting about 21% of participants at the highest dose

Effects of glucagon-like peptide-1 on oxidative stress and Nrf2 signaling